Humana and University of Miami create a unique research center.
NATIONAL REPORTS-In what experts are calling an "innovative marriage of the academic and private sectors," the University of Miami (Florida) and Humana are creating a center to conduct clinical, behavioral and health-services research to help keep individuals healthy and reduce healthcare costs.
The Health Services Research Center is a collaborative effort between Humana and the University of Miami Leonard M. Miller School of Medicine. The center will be jointly governed by a board that includes members from Humana and the University of Miami, as well as an independent scientific advisory board that includes experts from all aspects of the healthcare industry.
The University of Miami/Humana Health Services Research Center is dedicated to searching for new ways to prevent disease and manage chronic illness. One feature of the center will be a Health Behavior Change Laboratory, which will integrate Humana's personal nurse coaching services into the university's clinical settings. It is a unique public-private partnership devoted to clinical, health services and policy research, with a focus on influencing behaviors to improve chronic disease among South Florida's diverse population.
This pre-disease management "moves farther back in the ill health chain than traditional DM," according to MHE Editorial Advisor Al Lewis, president of the Disease Management Purchasing Consortium in Wellesley, Mass. "If successful, Humana will be the first to put an economic value on leading a healthy life, just as they were the first to do disease management at all, back in 1996," Lewis says.
NO DISEASE STATE UNTURNED The research center will not exclude any disease states, according to Dr. Han. "However, diseases that benefit from behavior change, such as heart disease and diabetes will be a priority," she says. "By targeting diseases and conditions that are amendable to behavior and lifestyle changes and management, we will prove that health creates wealth for all stakeholders. In other words, a healthy person who invests in health today will generate huge, long-term financial benefits through savings on future health expenditures."
The center will use both Humana members as well as non-Humana members. However, the center will have access to richer data for Humana members because it will have both the university's clinical data and Humana's claims data.
"All health plans have vast data for their members," Dr. Han says. "However, Humana is turning its data into knowledge on how to help consumers live healthier lives. Humana's sophistication in statistical analysis using things such as physician visits, diagnosis codes and prescription records, helps the company produce models for predicting the trajectory of illness."
Humana and the university plan to publish their findings in medical and healthcare journals and publications.
For another plan to do what Humana is doing, "they'd have to be equivalent to Humana in having excellent claims availability, a personal nurse program and a relationship with an academic center," according to Lewis. "Very few others have all three."
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Study Raises Concerns Over Insurance Barriers to HIV Prevention Medications
November 29th 2023Despite its efficacy, PrEP remains underutilized compared to the need for it. High costs are among the barriers to PrEP use, along with limited knowledge among clinicians, lack of health insurance, stigma, and underestimation of personal HIV risk.
Read More